CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.
Peter K. H. Lau, S.J. Harris, Melissa Eastgate, Damien Kee, Andrew Mant, Louise M. Nott, Craig Gedye, Andrisha Jade Inderjeeth, Craig Underhill, Alison M. Weppler, Roslyn Wallace, Belinda Lee, George Au‐Yeung, Narelle Williams, Daniel Ariza Ospino, Louise Gonzales, Mark Shackleton, Serigne Lo, Grant A. McArthur, Shahneen Sandhu (2023). CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.9525.
